MethodologyThe ACCP is at the forefront of defining the methodologic science of guideline development. The lung cancer guidelines are distinguished by this methodologic rigor and is a body of work that is as evidence-based, unbiased, and scientifically accurate as possible. The process involved thousands of hours and systematic reviews of the available data, conducted by over 100 expert panel members, including pulmonologists, medical oncologists, radiation oncologists, thoracic surgeons, integrative medicine specialists, oncology nurses, pathologists, health-care researchers, and epidemiologists, as well as trained methodologists. The guidelines were further reviewed and approved by the ACCP Thoracic Oncology NetWork, the Guidelines Oversight Committee, the ACCP Board of Regents, and external reviewers from the journal CHEST. The guidelines have been endorsed by the European Society of Thoracic Surgeons, Oncology Nursing Society, American Association for Bronchology and Interventional Pulmonology, and The Society of Thoracic Surgeons.About Lung Cancer in the United States Lung cancer continues to be the leading cause of cancer deaths in men and women in the United States and across the world, causing more deaths than the next four most common cancers combined, including colon, breast, pancreas, and prostate. Deaths from lung cancer in women surpassed those due to breast cancer in 1987. Declining rates of smoking have slowly reduced the rates of lung cancer, and the majority of those diagnosed with this disease today successfully quit smoking years earlier. Nevertheless, lung cancer remains a common cancer, even in lifelong never-smokers.
New Lung Cancer Guidelines Recommends Offering Screening To High-Risk Individuals
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.